Accelerated Loss of TCR Repertoire Diversity in Common Variable Immunodeficiency by Wong, Gabriel K. et al.
Accelerated Loss of TCR
Repertoire Diversity in Common
Variable Immunodeficiency
The Harvard community has made this
article openly available.  Please share  how
this access benefits you. Your story matters
Citation Wong, Gabriel K., David Millar, Sarah Penny, James M. Heather,
Punam Mistry, Nico Buettner, Jane Bryon, Aarnoud P. Huissoon, and
Mark Cobbold. 2016. “Accelerated Loss of TCR Repertoire Diversity
in Common Variable Immunodeficiency.” The Journal of Immunology
Author Choice 197 (5): 1642-1649. doi:10.4049/jimmunol.1600526.
http://dx.doi.org/10.4049/jimmunol.1600526.
Published Version doi:10.4049/jimmunol.1600526
Citable link http://nrs.harvard.edu/urn-3:HUL.InstRepos:29002449
Terms of Use This article was downloaded from Harvard University’s DASH
repository, and is made available under the terms and conditions
applicable to Other Posted Material, as set forth at http://
nrs.harvard.edu/urn-3:HUL.InstRepos:dash.current.terms-of-
use#LAA
The Journal of Immunology
Accelerated Loss of TCR Repertoire Diversity in Common
Variable Immunodeficiency
Gabriel K. Wong,*,† David Millar,‡,x Sarah Penny,* James M. Heather,{
Punam Mistry,* Nico Buettner,* Jane Bryon,‖ Aarnoud P. Huissoon,† and
Mark Cobbold‡,x
Although common variable immunodeficiency (CVID) has long been considered as a group of primary Ab deficiencies, growing
experimental data now suggest a global disruption of the entire adaptive immune response in a segment of patients. Oligoclonality of
the TCR repertoire was previously demonstrated; however, themanner in which it relates to other B cell and T cell findings reported
in CVID remains unclear. Using a combination approach of high-throughput TCRb sequencing and multiparametric flow
cytometry, we compared the TCR repertoire diversity between various subgroups of CVID patients according to their B cell
immunophenotypes. Our data suggest that the reduction in repertoire diversity is predominantly restricted to those patients with
severely reduced class-switched memory B cells and an elevated level of CD21lo B cells (Freiburg 1a), and may be driven by a
reduced number of naive T cells unmasking underlying memory clonality. Moreover, our data indicate that this loss in repertoire
diversity progresses with advancing age far exceeding the expected physiological rate. Radiological evidence supports the loss in
thymic volume, correlating with the decrease in repertoire diversity. Evidence now suggests that primary thymic failure along
with other well-described B cell abnormalities play an important role in the pathophysiology in Freiburg group 1a patients.
Clinically, our findings emphasize the integration of combined B and T cell testing to identify those patients at the greatest risk for
infection. Future work should focus on investigating the link between thymic failure and the severe reduction in class-switched
memory B cells, while gathering longitudinal laboratory data to examine the progressive nature of the disease. The Journal of
Immunology, 2016, 197: 1642–1649.
T
he Ag receptor repertoire is a distinctive feature of the
adaptive immune system that enables the recognition of a
vast potential of Ags. The process of Ag receptor gene
rearrangement (VDJ) provides each T lymphocyte its own unique
Ag binding characteristic and molecular signature, each contrib-
uting to the tremendous diversity within our immune repertoires
(1). The diversity of a T cell immune repertoire is maintained by
continuous outputs from the thymus, although it evidently di-
minishes as part of the normal aging process (2).
Common variable immunodeficiency (CVID) has long been
considered as a primary Ab deficiency, although growing experi-
mental data now suggest a global disruption of the entire adaptive
immune response. Assessments of the IgH and TCR repertoires in
the past have demonstrated gross abnormalities in both B cell and
T cell compartments (3–5).
It has been proposed that the observed T cell oligoclonality in
CVID is predominantly driven by the abnormal expansion of
CD8+ T cells, with an unexplained bias toward particular V-genes
dominating the TCR repertoire, although a similar, albeit distinct,
pattern has also been observed in CD4 T cells (4–6). CD8 oli-
goclonality appears to be unique to CVID, because age-matched
X-linked agammaglobulinemia patients tend to have normal di-
versity in their CD8 repertoire (4). To further support the over-
expansion of CD8+ T cells, replicative senescence has been
reported in the T cells of CVID patients (7). In addition, immu-
nophenotypic data have consistently demonstrated the increased
expression of CD95, CD38, and HLA-DR along with elevated
levels of CD57 and PD-1 on CD8+ T cells, indicating their active
inflammatory role with evidence of exhaustion (8–11). Given
closer HLA sharing among CVID patients (12, 13), the combi-
nation of Vb gene restriction and an activated CD8 phenotype
suggests the presence of common antigenic drivers behind their
expansion.
Large cohort studies have revealed, however, that only a small
proportion of patients have elevated peripheral absolute CD8+
T cell counts (8, 14). Importantly, a reversed CD4:CD8 ratio
was often a result of CD4 lymphopenia without dramatic al-
teration in the absolute CD8+ T cell count (8, 14). Hence the
overall influences on the repertoire diversity of CD8+ T cells
remain unexplained, and may be restricted solely to a subgroup
of patients.
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Recent evidence using more powerful molecular approaches
suggests that the restriction of the TCR repertoire in CVID may
be related to an intrinsic defect, such as reduced junctional di-
versity and V-region deletion, as opposed to a response to an
extrinsic chronic antigenic driver (3), thus revising our under-
standing of CVID as a combined T cell and B cell immunode-
ficiency. Nevertheless, the reported intrinsic repertoire defect
was relatively subtle, with many patients carrying a normal TCR
repertoire. Given the known heterogeneity of CVID, we hy-
pothesize that immune repertoire defects are restricted to a
subgroup of patients, and that analysis according to an interna-
tionally agreed classification would facilitate in relating the
repertoire defect to previously described experimental findings
with greater accuracy.
This study describes and compares the TCR repertoire diversity
between subgroups of CVID patients according to their B cell
immunophenotypes (15). Using a combination approach of high-
throughput TCR sequencing and multiparametric flow cytometry,
our data suggest that a loss of TCR repertoire diversity is pre-
dominantly found in Freiburg 1a patients in a progressive manner.
Consistent with previous reports, a reduction of naive T cells
appeared to be a driver for oligoclonality and increased risk for
infection (5, 10); in contrast, the role of effector memory CD8+
T cells in altering the repertoire diversity is less apparent.
Materials and Methods
Participants and ethics
This study was conducted according to protocols approved by the South
Birmingham Research Ethics Committee, National Research Ethics Ser-
vice, U.K. (REC reference: 11/WM/0041), and was sponsored by the
University of Birmingham (Reference: RG_10-260). Written consent was
obtained from all participants in accordance with the Declaration of
Helsinki. Forty-two patients with CVID were recruited from the West
Midlands Immunodeficiency Centre, U.K., all of whom were diagnosed
according to the European Society of Immunodeficiencies and Pan
American Group for Immunodeficiency criteria. The CVID patients were
subclassified according to their peripheral blood B cell subsets (,1%
peripheral B cells, Freiburg 1a = ,0.4% switched memory B cells of
PBLs and .20% CD21lo B cells of total B cells, Freiburg 1b = ,0.4%
switched memory B cells and ,20% CD21lo B cells, and Freiburg 2 =
.0.4% switched memory B cells) (15). The patients’ characteristics are
given in Supplemental Table I. Clinical, laboratory, and radiological data
were collated with the findings of this study. Finally, age-matched healthy
donors were recruited from within the University of Birmingham as
control subjects.
Next-generation sequencing of TCRb repertoire
The genomic DNA of the healthy donors and CVID patients were obtained
by extraction from 2.5 3 106 PBMCs using the ISOLATE II Genomic
DNA Kit (Bioline) or DNeasy Blood & Tissue Kit (Qiagen) according to
the standard manufacturer’s protocols. The TCRb repertoires were
assessed via the ClonoSIGHT platform (Sequenta) as previously described
(16). All raw antisense nucleotide TCRb sequences obtained were
reverified and converted to amino acid TCRb sequences through the IMGT
online-based bioinformatics tool (http://www.imgt.org), HighV-Quest,
under the following settings: species = human; locus = TCRb; single in-
dividual, nucleotide per line in alignments = 60; aligned reference se-
quences = 5. Details of sequencing output are provided in Supplemental
Table II.
T cell repertoire diversity and V-gene usage
Relative repertoire diversity was estimated by Shannon entropy (S.E.;
natural log: ln) [H =2S p(x) ln p(x); p(x) = frequency of individual amino
acid TCRb sequences] and inverse Simpson index [1/l = 1/S p(x)2] as
previously described (17–19), with only the in-frame productive TCRb
sequences being considered in the calculation. Higher scores were gen-
erated for polyclonal samples, whereas a lower score indicated clonality.
V-gene usages of all subgroups were compared by Jenson–Shannon di-
vergence (JSD) (20).
Multiparametric flow cytometry
A whole blood staining protocol was used for the peripheral blood
T cell immunophenotyping. Four hundred fifty milliliters of EDTA
blood was labeled with anti–CD3-PE.Cy5, anti–CD4-BV711, anti–
CD8a-allophycocyanin, anti–CD45RA-BV510, anti–CD27-BV605, anti–
CD28-PE/Cy7, anti–CCR7-PE/Cy5.5, and anti-CD25-allophycocyanin/
Cy7 Abs (Biolegend) to determine various T cell subpopulations. Abs
were used in 1:100 dilutions and incubated at room temperature for
20 min in the dark. All cells were washed with isotonic PBS with 2%
FCS and incubated with 2 ml of 0.16 M of NH4CL at room temper-
ature in the dark for 10 min for red cell lysis. A final wash with PBS
and 2% FCS was carried out, and 0.5 ml of 1% paraformaldehyde was
added. CountBright Absolute Counting Beads (Life Technologies)
were added according to manufacturer’s protocol for accurate cell
counting. Compensation was aided by the Anti-Mouse Ig, k/Negative
Control Compensation Particles Set (BD Biosciences) and automati-
cally calculated by BD FACSDiva software version 6.0. Acquisition
was performed via BD LSR Fortessa flow cytometer (BD Biosciences)
and analyzed via FlowJo version 7.6.5 software.
Statistical analysis
Statistical analyses were performed through GraphPad Prism version 5.0.
Comparisons between nonparametric data sets were done via the two-tailed
Mann–Whitney U test, whereas analysis of covariance (ANCOVA) and Kruskal–
Wallis test were done via IBM SPSS statistic 21. The p values considered to
be statistically significant were: *p , 0.05, **p , 0.01, and ***p , 0.001.
Results
Accelerated reduction in T cell repertoire diversity in Freiburg
1a patients
TCRb next-generation sequencing was carried out to determine
the level of TCR diversity in the CVID patients by using the ge-
nomic DNA extracted from the PBMCs. All nucleotide sequences
were verified by the HighV-Quest tool to derive their V-J family
usages and nongermline CDR3 amino acid sequences (Fig. 1A).
Only productive sequences were considered for further analysis.
Graphical examples of a polyclonal and a clonal TCR repertoire
are shown in Fig. 1B, with distinct and abnormal peaks presenting
in the clonal repertoire, but not in the polyclonal repertoire. TCR
repertoire diversity was compared using S.E. (Fig. 1C), inverse
Simpson’s diversity index, and cumulative percentage of the top
10 CDR3 sequences (Supplemental Fig. 1A, 1B). All three metrics
demonstrated simple findings. According to Warnatz and col-
leagues (15), the CVID patients were classified into Freiburg
group 1a (,0.4% class-switched memory B cells in peripheral
blood, .20% CD21lo B cells), Freiburg group 1b (,0.4% class-
switched memory B cells in peripheral blood, ,20% CD21lo
B cells), and Freiburg group 2 (.0.4% class-switched memory
B cells). Age-matched healthy donors were recruited as control
subjects (median age: healthy control [HC] = 43, all CVID = 45,
Freiburg 1a = 45, Freiburg 1b = 41, Freiburg 2 = 40.5). The CVID
patients as a whole demonstrated normal TCR repertoire diversity
when compared with the healthy donors, whereas a significant
decrease was detected in the Freiburg 1a patients (p = 0.009). By
contrast, normal repertoire diversities were detected in the Frei-
burg 1b and Freiburg 2 patients.
To detect the potential source of oligoclonality in the Freiburg 1a
patients, we divided the amino acid TCRb sequences into low
frequency (small: ,0.001%), medium (0.001–0.01%), large (0.01–
1%), or hyperexpanded (.1%), and compared their percentage
occupancies in the repertoire between various subgroups of pa-
tients (2). Our data showed a significant reduction in low-
frequency (,0.001%) amino acid TCRb sequences uniquely in
Freiburg 1a patients, but no other groups (HC versus Freiburg
1a, p = 0.007; Fig. 1D), whereas the overall occupancies of
medium-to-hyperexpanded TCRb sequences were unaffected
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(Supplemental Fig. 1C). The normality of the medium-to-hyperexpanded
compartments strongly suggests a loss of low-frequency (,0.001%)
TCRb sequences as the source of oligoclonality. Furthermore,
accelerated loss in repertoire diversity was noted with advancing
age in the Freiburg 1a patients when compared with the other
groups (ANCOVA, p = 0.023; Fig. 1E).
JSD was used to compare V-gene usage between subgroups of
patients. Unweighted TCR sequences, where the frequencies or
FIGURE 1. Next-generation sequencing of TCRb-chain and assessment of repertoire diversity. TCR deep sequencing was carried out on the PBMCs of
healthy donors and CVID patients according to the ClonoSIGHT platform. (A) Raw nucleotide sequences were converted into amino acid TCRb sequences
using IMGT’s HighV-Quest (left). (B) Graphic examples of a polyclonal (left) and a clonal (right) repertoire are shown according to the relative usage of V- and
J-gene segments. (C and D) Repertoire diversity by S.E. and amino acid TCRb sequences of ,0.001% were compared among healthy donors (n = 15, gray
circle), all CVID patients (n = 42, open circle), Freiburg group 1a patients (n = 7, open triangle), group 1b patients (n = 9, black triangle), and group 2 patients
(n = 16, open square). (E) Repertoire diversity versus age is shown. JSDs of unweighted (F) and weighted (G) intragroup analyses (HC versus all CVID, HC versus
Freiburg 1a, HC versus Freiburg 1b, HC versus Freiburg 2, Freiburg 1a versus Freiburg 1b, Freiburg 1a versus Freiburg 2, and Freiburg 1b versus Freiburg 2) are
shown. The medians and interquartile ranges are depicted. Statistical differences highlighted by *, **, or *** (two-tailed Mann–Whitney U test and ANCOVA).
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reads of individual sequences were not considered, showed no
differences in V-gene usage between all groups (Fig. 1F). By
contrast, JSD of weighted TCR sequences, where the frequencies
of individual sequences were accounted for, demonstrated greater
distance of Freiburg 1a patients from the other groups, indicating
abnormal V-gene selection after clonal expansion (Fig. 1G). Fi-
nally, the numbers of P and N nucleotide insertion and deletion by
both weighted and unweighted analyses were similar between all
groups, with only a marginal increase in unweighted V, D, and J
segment deletion observed in Freiburg 1a patients (Supplemental
Fig. 1D, 1E).
Overall, our data indicate that the progressive loss of low-
frequency (,0.001%) TCRb sequences may reduce the reper-
toire diversity in Freiburg 1a patients, with evidence of disparate
V-gene selection for clonal expansion.
Reduction in naive T cells correlates with decreased repertoire
diversity
Given that low-frequency (,0.001%) TCRb sequences are likely
to represent unexpanded naive T cells, the correlation between
naive T cell count and TCRb repertoire diversity was further
examined. CD4+ and CD8+ naive T cells (CCR7+CD45RA+
CD28+CD27+) were determined by multiparametric flow cytom-
etry and accurately calculated via counting beads (Fig. 2A). A good
correlation was observed between the percentage of naive T cells
and the percentage of low-frequency (small) TCR sequences, in-
FIGURE 2. Correlations between repertoire diversity and peripheral naive T cells. Peripheral blood T cell subpopulations were enumerated using
counting beads via multiparametric flow cytometry. (A) An example of the gating strategy is presented. (B) Naive (N:CCR7+CD45RA+CD28+CD27+) CD4
T cell counts and frequencies of healthy donors (n = 8, gray), Freiburg group 1a patients (n = 2, open triangle), group 1b patients (n = 5, black triangle), and
group 2 patients (n = 5, open square) are shown. (C) Naive CD4 T cell counts and frequencies are plotted against TCRb repertoire diversity (S.E.). The
black lines represent the best fit line with r2 depicted adjacently. (D) Naive CD8 T cell counts and frequencies of healthy donors, CVIDs, Freiburg group 1a
patients, group 1b patients, and group 2 patients are shown. (E) Naive CD8 T cell counts and frequencies are plotted against TCRb repertoire diversity.
Medians and interquartile ranges are depicted. Statistical differences are highlighted by *, **, or *** (two-tailed Mann–Whitney U test).
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dicating that low-frequency TCR sequences were representative of
the unexpanded naive pool (Supplemental Fig. 2A).
Reduced naive CD4+ T cell frequency and absolute count were
seen in all subgroups of CVID patients (median cell count: HC =
384 mm3, Freiburg 1a/b = 77 mm3 [p = 0.01], Freiburg 2 = 24 mm3
[p = 0.002]; median frequency: HC = 38.0%, Freiburg 1a/b = 10.9%
[p = 0.023], Freiburg 2 = 6.2% [p = 0.029]), with a positive cor-
relation found between naive CD4+ T cells and S.E. repertoire di-
versity (Fig. 2B, 2C). A similar magnitude of naive CD8+ T cell
decrease was also observed in all patients, where a positive corre-
lation was demonstrated with repertoire diversity (median cell
count: HC = 193 mm3, Freiburg 1a/b = 6 mm3 [p = 0.001], Freiburg
2 = 7 mm3 [p = 0.006]; median frequency: HC = 36.2%, Freiburg
1a/b = 9.2% [p = 0.004], Freiburg 2 = 2.4% [p = 0.003]) (Fig. 2D,
2E). A good linear correlation between the frequencies of naive
CD4 and naive CD8 T cells could be seen, which supports a global
deficiency in the naive T cell pool (Supplemental Fig. 2B).
In contrast, other T cell subpopulation counts such as effector
memory (CCR72CD45RA2), central memory (CCR7+CD45RA2
CD27+CD28+), and terminally differentiated memory T cells
(TEMRA: CCR72CD45RA+) were largely normal, suggesting
that the T cell memory compartments in CVID are relatively less
affected (Supplemental Fig. 2C).
Reduction in thymic volume in Freiburg 1a/b patients
Next, we tested whether the decrease in naive T cells was related
to the reduction in thymic output by assessing the thickness,
anteroposterior, craniocaudal, and transverse lengths of thymus
on high-resolution computed tomography (CT) scans (Fig. 3A).
Thymoma was not found in any of the patients. Notably, smaller
and hypodense thymi were observed among Freiburg 1a and
Freiburg 1b patients when compared with the age-matched
published reference range (median thymic thickness: Freiburg
1a = 0.38 cm, Freiburg 1b = 0.30 cm). However, the Freiburg
group 2 patients were noted to have normal thymic thickness
(median: 0.73 cm) (Fig. 3B) (21). Our data showed that all
thymic dimensions positively correlated with repertoire diversity
(Fig. 3C). Hence the loss in thymic volume is supportive of a
decrease in thymic output, leading to a peripheral reduction in
naive T cells and repertoire diversity in a proportion of CVID
patients.
Reduction in repertoire diversity exacerbates infection
outcome in CVID
In view of the reduced repertoire diversity and naive T cells, we
further hypothesized that there would be limited cognate T cells
for T-dependent Ab responses, resulting in more frequent in-
fections. To test this, we examined repertoire diversity against the
severity of bronchiectasis and annual requirement for antibiotics,
with the former graded as none, mild, or moderate-to-severe
according to the CT findings. Reduction in repertoire diversity
was observed in those patients with moderate-to-severe bron-
chiectasis (median S.E.: mild bronchiectasis = 11.0 [p = 0.953],
moderate-to-severe bronchiectasis = 10.1 [p = 0.012]) (Fig. 4A).
Similarly, patients with reduced repertoire diversity required
more courses of antibiotics per year (Fig. 4B). However, we
observed no statistical differences in peripheral blood naive
CD4+ and CD8+ counts among the various bronchiectatic groups
(Fig. 4C, 4D), indicating that the qualitative assessment of
T cells by repertoire diversity may be a more superior predictor
for infection risk than mere numerical T cell counts in CVID
patients.
FIGURE 3. Thymic dimensions in CVID. Thymic size was assessed using a high-resolution CT scan and comparing this with an age-matched published
reference range and repertoire diversity. (A) Examples of a full thymus (left: 20-year-old CVID patient) and a small hypodense thymus (right: 29-year-old
CVID patient) are shown. (B) The thymic thickness (in centimeters) of CVID (open square, n = 30), Freiburg group 1a (open triangle, n = 7), Freiburg group
1b (open inverted triangle, n = 4), and Freiburg group 2 patients (open diamond, n = 16), and the expected range of individuals between 40 and 50 y of age
(gray; mean and SD) obtained from Francis et al. (21) are presented. (C) Thymic dimensions (thickness, anteroposterior, craniocaudal, and transverse
lengths in centimeters) are plotted against repertoire diversity. Black lines represent the best fit line with the equation, with the r2 values described ad-
jacently. Medians and interquartile ranges are depicted.
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Unique TCR amino CDR3 sequences in CVID patients
Finally, given the autoimmune association of CVID, we explored
whether shared unique TCR amino acid CDR3 sequences could be
found among patients. A TCR amino acid CDR3 sequence that
occupied .0.01% of the repertoire was considered a significant
immune response in an individual. All significant sequences were
then cross-searched between all participants. Our search identified
445 sequences shared by more than one individual within our
cohort of healthy donors and patients. Of these 445 sequences, 33
were unique to the healthy donors (n = 15), 26 to the Freiburg
group 2 patients (n = 16), and 6 to the Freiburg group 1b patients
(n = 8), but only 3 were unique to the Freiburg group 1a patients
(n = 7). Interestingly, all 3 Freiburg 1a unique sequences (100%)
commenced with the TRBV 6-2 gene segment despite no en-
richment of this V-gene in the repertoire when weighted and un-
weighted V-gene usage analyses were performed. In contrast,
the healthy donors, Freiburg 1b, and Freiburg group 2 patients
exhibited a greater diversity in the range of V-gene segment
expressed in their unique sequence pools (Fig. 5). However, the
significance of these observations is not clear.
Discussion
This study demonstrated that a restriction in T cell repertoire di-
versity is predominantly found in Freiburg group 1a patients, but
not in other CVID patients. In addition, our data support that this
reduction in repertoire diversity is in part due to a decrease of naive
T cells and may worsen infection rate and bronchiectasis. Despite it
being recognized that thymic output gradually declines with age, it
is known to be active well into the seventh decade, and our data
suggest the progressive loss in repertoire diversity in Freiburg 1a
patients far exceeds the expected physiological rate (22). However,
the loss of repertoire diversity by subtle clonal memory T cell
expansion, as opposed to a decrease of naive T cells, cannot be
completely ruled out. Although the larger TCRb sequence pools
and T cell memory compartments on immunophenotyping were
normal, the higher cumulative frequency of the top 10 CDR3
sequences in Freiburg group 1a patients would support this notion.
Nevertheless, the collective decrease in TCR repertoire diver-
sity, naive T cells, and thymic volume was consistent with ortho-
gonal evidence supporting thymic failure in CVID patients (3, 23).
Molecular studies have revealed that the numbers of copies of
TCR excision circles were significantly reduced and CD31+ recent
thymic immigrants were lower in CVID patients when compared
with healthy donors (10, 24, 25). Moreover, other thymic-derived
populations including naive, regulatory, and invariant NK T cells
were all reported in lower frequencies in patients with CVID (14,
23, 26, 27). Although there is heterogeneity in the classification
systems used in these studies, it is not surprising to note that the
majority of defects were described in patients with low class-
switched memory B cells, a high proportion of CD21lo B cells,
splenomegaly, and autoimmune cytopenias, thus gravitating this
phenomenon toward the Freiburg 1a classification (15).
FIGURE 4. Repertoire diversity and infection burden. The effect of repertoire diversity on infection burden was assessed by correlating to the severity of
bronchiectasis, use of antibiotics, and peripheral blood naive CD4 and CD8 counts. (A) Bronchiectasis was subclassified into none (open circle white), mild
(open square), or moderate-to-severe (open triangle) according to the CT scan findings (n = 42). Repertoire diversities by S.E. of various bronchiectatic
groups are shown. (B) The number of courses of antibiotics required by patients is plotted against the S.E. Black lines represent the best fit line with r2
values described adjacently. (C) Peripheral blood naive CD4 and CD8 T cell counts in various bronchiectatic groups are presented. Medians and inter-
quartile ranges are depicted. Statistical differences were determined by two-tailed Mann–Whitney U test. *p , 0.05.
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Although the T cell counts were low in all the CVID patients,
different pathological mechanisms may be involved between
subgroups. A number of intrinsic and extrinsic factors such as stress
and infections are known to influence the thymic function. In mice,
although infection with Salmonella resulted in transient thymic
atrophy because of the loss in thymocytes, recovery was seen
postinfection (28, 29). Similar observations have been made in
rabies, HIV, Mycobacterium, tularemia, and Listeria infections,
although these are uncommon in CVID (30, 31). Our data are
currently unable to differentiate primary thymic failure from
secondary causes. Given that low naive T cell counts were seen in
all CVID patients, the difference in their TCR repertoire diversi-
ties may actually stem from the memory compartment. The cu-
mulative frequencies of the top 10 CDR3 sequences, as well as
weighted JSD V-gene analysis, actually hinted a masked oligo-
clonality memory compartment, which may only be apparent in
patients with sufficient loss of naive T cells. However, our anal-
yses were carried out on whole PBMCs, which is a major weak-
ness of this study. To address this more accurately, future
experiments should aim at analyzing purified naive and memory
T cells to pinpoint the source of oligoclonality.
The progressive loss in repertoire diversity and thymic function
are in line with the late onset of the disease. The lack of cognate
T cells by primary or secondary primary thymic dysfunction may
impair T-dependent Ab responses, thus exacerbating infection
control. Conforming to this, the failure of humoral immunity also
occurs later in life for the majority of patients. In the future, it
would be of interest to examine whether arrest in thymic output
coincides with the timing of humoral failure.
Although unweighted V-gene usage analysis suggested that thymic
TCR synthesis was relatively normal in all patients, weighted V-gene
usage analysis suggested that V-gene selection for clonal T cell
expansion may be specifically altered in Freiburg 1a patients. This
finding is consistent with previous studies showing preferential
V-gene usage in CVID patients (3, 4, 6, 32). Moreover, our data
revealed a highly restrictive set of TRBV 6-2 unique CDR3 se-
quences in Freiburg 1a patients. Although interesting, the relevance
of these sequences is currently speculative. Without the knowledge
of the patients’ HLA types, it is not feasible to determine their pu-
tative Ag targets. Furthermore, a number of these sequences may be
Ag independent. Future work involving high-throughput TCR se-
quencing on enriched T cell subpopulations or cloned T cells with
the knowledge of the full ab conformation and patients’ HLA types
is required to better characterize the biophysical characteristics of
these unique CDR3 sequences. The emergence of standardized,
multiparametric bioinformatics tools, such as VDJtools (33), is likely
to further our understanding in this field. Finally, there is a need to
strengthen the observation made between infection rate and reper-
toire diversity with more robust data because the current conclusion
may be subjected to reporting bias from incomplete hospital records.
In summary, primary thymic dysfunction appears to contribute
significantly to the TCR repertoire defect in Freiburg group 1a
CVID patients. The progressive nature of CVID is highlighted in
this study. Clinically, our findings emphasize the integration of
combined B and T cell testing to identify those patients with the
greatest risk for infection, particularly when the revised European
Society for Immunodeficiencies (2014) diagnostic criteria now
demand a more comprehensive assessment of the T cell com-
partment during the diagnostic workup. Future studies should aim
at purifying and examining the memory T cell compartment in
greater detail, as well as attempting to determine the putative T cell
targets in CVID.
FIGURE 5. V-gene usage of subgroup unique TCR sequences in healthy donors and CVIDs. Thirty-three unique shared amino acid CDR3 sequences to
healthy donors, 26 to the Freiburg group 2 patients, 6 to the Freiburg group 1b patients, and 3 to the Freiburg group 1a patients (n = 7) were identified. The
variation in V-gene usages of the unique shared sequences of subgroups is shown in the pie charts. Freiburg 1a patients expressed 100% usage of TRBV6-2
in their unique shared sequence pools.
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